Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa

May El Hachem, Giovanna Zambruno, Eva Bourdon-Lanoy, Annalisa Ciasulli, Christiane Buisson, Smail Hadj-Rabia, Andrea Diociaiuti, Carolina F. Gouveia, Angela Hernández-Martín, Raul De Lucas Laguna, Mateja Dolenc-Voljč, Gianluca Tadini, Guglielmo Salvatori, Cristiana De Ranieri, Stephanie Leclerc-Mercier, Christine Bodemer

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by fragility and blistering of skin and mucous membranes. Clinical features combined with immunofluorescence antigen mapping and/or electron microscopy examination of a skin biopsy allow to define the EB type and subtype. Molecular diagnosis is nowadays feasible in all EB subtypes and required for prenatal diagnosis. The extent of skin and mucosal lesions varies greatly depending on EB subtype and patient age. In the more severe EB subtypes lifelong generalized blistering, chronic ulcerations and scarring sequelae lead to multiorgan involvement, major morbidity and life-threatening complications. In the absence of a cure, patient management remains based on preventive measures, together with symptomatic treatment of cutaneous and extracutaneous manifestations and complications. The rarity and complexity of EB challenge its appropriate care. Thus, the aim of the present study has been to generate multicentre, multidisciplinary recommendations on global skin care addressed to physicians, nurses and other health professionals dealing with EB, both in centres of expertise and primary care setting. Methods. Almost no controlled trials for EB treatment have been performed to date. For this reason, recommendations were prepared by a multidisciplinary team of experts from different European EB centres based on available literature and expert opinion. They have been subsequently revised by a panel of external experts, using an online-modified Delphi method to generate consensus. Results: Recommendations are reported according to the age of the patients. The major topics treated comprise the multidisciplinary approach to EB patients, global skin care including wound care, management of itching and pain, and early diagnosis of squamous cell carcinoma. Aspects of therapeutic patient education, care of disease burden and continuity of care are also developed. Conclusion: The recommendations are expected to be useful for daily global care of EB patients, in particular in the community setting. An optimal management of patients is also a prerequisite to allow them to benefit from the specific molecular and cell-based treatments currently under development.

Original languageEnglish
Article number76
JournalOrphanet Journal of Rare Diseases
Volume9
Issue number1
DOIs
Publication statusPublished - May 20 2014

Fingerprint

Epidermolysis Bullosa
Skin Care
Skin
Skin Manifestations
Continuity of Patient Care
Expert Testimony
Patient Education
Pain Management
Therapeutics
Pruritus
Rare Diseases
Prenatal Diagnosis
Cicatrix
Fluorescent Antibody Technique
Early Diagnosis
Squamous Cell Carcinoma
Primary Health Care
Electron Microscopy
Patient Care
Mucous Membrane

Keywords

  • Continuity of care
  • Disease burden
  • Inherited epidermolysis bullosa
  • Itch
  • Multidisciplinary management recommendations
  • Pain
  • Quality of life
  • Skin care
  • Therapeutic education
  • Wound care

ASJC Scopus subject areas

  • Medicine(all)
  • Genetics(clinical)
  • Pharmacology (medical)

Cite this

Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. / El Hachem, May; Zambruno, Giovanna; Bourdon-Lanoy, Eva; Ciasulli, Annalisa; Buisson, Christiane; Hadj-Rabia, Smail; Diociaiuti, Andrea; Gouveia, Carolina F.; Hernández-Martín, Angela; De Lucas Laguna, Raul; Dolenc-Voljč, Mateja; Tadini, Gianluca; Salvatori, Guglielmo; De Ranieri, Cristiana; Leclerc-Mercier, Stephanie; Bodemer, Christine.

In: Orphanet Journal of Rare Diseases, Vol. 9, No. 1, 76, 20.05.2014.

Research output: Contribution to journalArticle

El Hachem, M, Zambruno, G, Bourdon-Lanoy, E, Ciasulli, A, Buisson, C, Hadj-Rabia, S, Diociaiuti, A, Gouveia, CF, Hernández-Martín, A, De Lucas Laguna, R, Dolenc-Voljč, M, Tadini, G, Salvatori, G, De Ranieri, C, Leclerc-Mercier, S & Bodemer, C 2014, 'Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa', Orphanet Journal of Rare Diseases, vol. 9, no. 1, 76. https://doi.org/10.1186/1750-1172-9-76
El Hachem, May ; Zambruno, Giovanna ; Bourdon-Lanoy, Eva ; Ciasulli, Annalisa ; Buisson, Christiane ; Hadj-Rabia, Smail ; Diociaiuti, Andrea ; Gouveia, Carolina F. ; Hernández-Martín, Angela ; De Lucas Laguna, Raul ; Dolenc-Voljč, Mateja ; Tadini, Gianluca ; Salvatori, Guglielmo ; De Ranieri, Cristiana ; Leclerc-Mercier, Stephanie ; Bodemer, Christine. / Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. In: Orphanet Journal of Rare Diseases. 2014 ; Vol. 9, No. 1.
@article{0137ae8a90e64aa1ab54c61c9ad474c0,
title = "Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa",
abstract = "Background: Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by fragility and blistering of skin and mucous membranes. Clinical features combined with immunofluorescence antigen mapping and/or electron microscopy examination of a skin biopsy allow to define the EB type and subtype. Molecular diagnosis is nowadays feasible in all EB subtypes and required for prenatal diagnosis. The extent of skin and mucosal lesions varies greatly depending on EB subtype and patient age. In the more severe EB subtypes lifelong generalized blistering, chronic ulcerations and scarring sequelae lead to multiorgan involvement, major morbidity and life-threatening complications. In the absence of a cure, patient management remains based on preventive measures, together with symptomatic treatment of cutaneous and extracutaneous manifestations and complications. The rarity and complexity of EB challenge its appropriate care. Thus, the aim of the present study has been to generate multicentre, multidisciplinary recommendations on global skin care addressed to physicians, nurses and other health professionals dealing with EB, both in centres of expertise and primary care setting. Methods. Almost no controlled trials for EB treatment have been performed to date. For this reason, recommendations were prepared by a multidisciplinary team of experts from different European EB centres based on available literature and expert opinion. They have been subsequently revised by a panel of external experts, using an online-modified Delphi method to generate consensus. Results: Recommendations are reported according to the age of the patients. The major topics treated comprise the multidisciplinary approach to EB patients, global skin care including wound care, management of itching and pain, and early diagnosis of squamous cell carcinoma. Aspects of therapeutic patient education, care of disease burden and continuity of care are also developed. Conclusion: The recommendations are expected to be useful for daily global care of EB patients, in particular in the community setting. An optimal management of patients is also a prerequisite to allow them to benefit from the specific molecular and cell-based treatments currently under development.",
keywords = "Continuity of care, Disease burden, Inherited epidermolysis bullosa, Itch, Multidisciplinary management recommendations, Pain, Quality of life, Skin care, Therapeutic education, Wound care",
author = "{El Hachem}, May and Giovanna Zambruno and Eva Bourdon-Lanoy and Annalisa Ciasulli and Christiane Buisson and Smail Hadj-Rabia and Andrea Diociaiuti and Gouveia, {Carolina F.} and Angela Hern{\'a}ndez-Mart{\'i}n and {De Lucas Laguna}, Raul and Mateja Dolenc-Voljč and Gianluca Tadini and Guglielmo Salvatori and {De Ranieri}, Cristiana and Stephanie Leclerc-Mercier and Christine Bodemer",
year = "2014",
month = "5",
day = "20",
doi = "10.1186/1750-1172-9-76",
language = "English",
volume = "9",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa

AU - El Hachem, May

AU - Zambruno, Giovanna

AU - Bourdon-Lanoy, Eva

AU - Ciasulli, Annalisa

AU - Buisson, Christiane

AU - Hadj-Rabia, Smail

AU - Diociaiuti, Andrea

AU - Gouveia, Carolina F.

AU - Hernández-Martín, Angela

AU - De Lucas Laguna, Raul

AU - Dolenc-Voljč, Mateja

AU - Tadini, Gianluca

AU - Salvatori, Guglielmo

AU - De Ranieri, Cristiana

AU - Leclerc-Mercier, Stephanie

AU - Bodemer, Christine

PY - 2014/5/20

Y1 - 2014/5/20

N2 - Background: Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by fragility and blistering of skin and mucous membranes. Clinical features combined with immunofluorescence antigen mapping and/or electron microscopy examination of a skin biopsy allow to define the EB type and subtype. Molecular diagnosis is nowadays feasible in all EB subtypes and required for prenatal diagnosis. The extent of skin and mucosal lesions varies greatly depending on EB subtype and patient age. In the more severe EB subtypes lifelong generalized blistering, chronic ulcerations and scarring sequelae lead to multiorgan involvement, major morbidity and life-threatening complications. In the absence of a cure, patient management remains based on preventive measures, together with symptomatic treatment of cutaneous and extracutaneous manifestations and complications. The rarity and complexity of EB challenge its appropriate care. Thus, the aim of the present study has been to generate multicentre, multidisciplinary recommendations on global skin care addressed to physicians, nurses and other health professionals dealing with EB, both in centres of expertise and primary care setting. Methods. Almost no controlled trials for EB treatment have been performed to date. For this reason, recommendations were prepared by a multidisciplinary team of experts from different European EB centres based on available literature and expert opinion. They have been subsequently revised by a panel of external experts, using an online-modified Delphi method to generate consensus. Results: Recommendations are reported according to the age of the patients. The major topics treated comprise the multidisciplinary approach to EB patients, global skin care including wound care, management of itching and pain, and early diagnosis of squamous cell carcinoma. Aspects of therapeutic patient education, care of disease burden and continuity of care are also developed. Conclusion: The recommendations are expected to be useful for daily global care of EB patients, in particular in the community setting. An optimal management of patients is also a prerequisite to allow them to benefit from the specific molecular and cell-based treatments currently under development.

AB - Background: Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by fragility and blistering of skin and mucous membranes. Clinical features combined with immunofluorescence antigen mapping and/or electron microscopy examination of a skin biopsy allow to define the EB type and subtype. Molecular diagnosis is nowadays feasible in all EB subtypes and required for prenatal diagnosis. The extent of skin and mucosal lesions varies greatly depending on EB subtype and patient age. In the more severe EB subtypes lifelong generalized blistering, chronic ulcerations and scarring sequelae lead to multiorgan involvement, major morbidity and life-threatening complications. In the absence of a cure, patient management remains based on preventive measures, together with symptomatic treatment of cutaneous and extracutaneous manifestations and complications. The rarity and complexity of EB challenge its appropriate care. Thus, the aim of the present study has been to generate multicentre, multidisciplinary recommendations on global skin care addressed to physicians, nurses and other health professionals dealing with EB, both in centres of expertise and primary care setting. Methods. Almost no controlled trials for EB treatment have been performed to date. For this reason, recommendations were prepared by a multidisciplinary team of experts from different European EB centres based on available literature and expert opinion. They have been subsequently revised by a panel of external experts, using an online-modified Delphi method to generate consensus. Results: Recommendations are reported according to the age of the patients. The major topics treated comprise the multidisciplinary approach to EB patients, global skin care including wound care, management of itching and pain, and early diagnosis of squamous cell carcinoma. Aspects of therapeutic patient education, care of disease burden and continuity of care are also developed. Conclusion: The recommendations are expected to be useful for daily global care of EB patients, in particular in the community setting. An optimal management of patients is also a prerequisite to allow them to benefit from the specific molecular and cell-based treatments currently under development.

KW - Continuity of care

KW - Disease burden

KW - Inherited epidermolysis bullosa

KW - Itch

KW - Multidisciplinary management recommendations

KW - Pain

KW - Quality of life

KW - Skin care

KW - Therapeutic education

KW - Wound care

UR - http://www.scopus.com/inward/record.url?scp=84905381117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905381117&partnerID=8YFLogxK

U2 - 10.1186/1750-1172-9-76

DO - 10.1186/1750-1172-9-76

M3 - Article

C2 - 24884811

AN - SCOPUS:84905381117

VL - 9

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

IS - 1

M1 - 76

ER -